Ocera Therapeutics fka OCRX

[bbking2003]

stock's been holding on pretty much here it has strength to go forward looks like! No one wants to sell down this way insiders are holding institutions are holding plus I agree with your post It's time for the stock to move back up and I believe we're very close to it now proprietary MATCH™ technology is Going to be a winner for TRANZYME! "There is no doubt that within the last 3-4 years it has been a lot easier to get pharma's attention from a collaboration standpoint," said Tranzyme Inc. VP of IP and operations Mark Peterson. Tranzyme partnered its macrocycle discovery platform with Bristol-Myers Squibb Co. in 2009.

Indeed, collaboration looks to be essential to solving the puzzle of cell access. At this point, all the lead programs disclosed thus far are aiming at extracellular targets!